Lakefront Biotherapeutics/$LKFT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Lakefront Biotherapeutics
Lakefront Biotherapeutics NV a biopharmaceutical company committed to improving the lives of people with severe diseases. It focuses on delivering medicines with transformational impact for patients by accelerating life-changing science and innovation in areas of high unmet need. Its pipelines includes GLPG3667, GLPG5101, and GLPG5301.
Ticker
$LKFT
Sector
Primary listing
Employees
704
Headquarters
Website
LKFT Metrics
BasicAdvanced
$1.8bn
3.14
$8.70
-
-
Price and volume
Market cap
$1.8bn
52-week high
$37.78
52-week low
$24.74
Average daily volume
161k
Financial strength
Current ratio
30.478
Quick ratio
30.235
Long term debt to equity
0.149
Total debt to equity
0.198
Interest coverage (TTM)
1,611.98%
Profitability
EBITDA (TTM)
777.979
Gross margin (TTM)
53.99%
Net profit margin (TTM)
46.83%
Operating margin (TTM)
60.39%
Effective tax rate (TTM)
-3.55%
Revenue per employee (TTM)
$1,736,780
Management effectiveness
Return on assets (TTM)
10.65%
Return on equity (TTM)
16.26%
Valuation
Price to earnings (TTM)
3.14
Price to revenue (TTM)
1.471
Price to book
0.47
Price to tangible book (TTM)
0.47
Price to free cash flow (TTM)
-4.946
Free cash flow yield (TTM)
-20.22%
Free cash flow per share (TTM)
-5.526
Growth
Revenue change (TTM)
262.17%
Earnings per share change (TTM)
-388.18%
3-year revenue growth (CAGR)
85.52%
10-year revenue growth (CAGR)
34.13%
3-year earnings per share growth (CAGR)
38.90%
10-year earnings per share growth (CAGR)
15.59%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Lakefront Biotherapeutics stock?
Lakefront Biotherapeutics (LKFT) has a market cap of $1.8B as of May 13, 2026.
What is the P/E ratio for Lakefront Biotherapeutics stock?
The price to earnings (P/E) ratio for Lakefront Biotherapeutics (LKFT) stock is 3.14 as of May 13, 2026.
Does Lakefront Biotherapeutics stock pay dividends?
No, Lakefront Biotherapeutics (LKFT) stock does not pay dividends to its shareholders as of May 13, 2026.
When is the next Lakefront Biotherapeutics dividend payment date?
Lakefront Biotherapeutics (LKFT) stock does not pay dividends to its shareholders.
What is the beta indicator for Lakefront Biotherapeutics?
Lakefront Biotherapeutics (LKFT) does not currently have a Beta indicator.